A phase 1/2 trial to evaluate the pharmacokinetics, safety, and efficacy of NI-03 in patients with chronic pancreatitis: study protocol for a randomized controlled trial on the assessment of camostat treatment in chronic pancreatitis (TACTIC)

This study may fill an important clinical gap to provide an effective medical treatment option for CP-associated pain.Trial registrationClinicalTrials.gov,NCT02693093. Registered through the National Institutes of Health on 26 February 2016.
Source: Trials - Category: Research Source Type: clinical trials